Beneficial associations have been found between ruminant trans fatty acids and insulin resistance and type 2 diabetes [39, 40], with potential mechanisms suggested in animal studies being inhibition of hepatic de novo lipogenesis, activation of PPAR-α and PPAR-γ, improving insulin sensitivity and reducing inflammation [40, 41]. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.